Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
CORV was delisted on the 26th of May, 2020.
31 hedge funds and large institutions have $38.7M invested in Correvio Pharma Corp. Ordinary Shares (Canada) in 2017 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 12 reducing their positions, and 3 closing their positions.
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
15% more funds holding
Funds holding: 27 → 31 (+4)
42% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 12
54% less capital invested
Capital invested by funds: $84.2M → $38.7M (-$45.5M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$4.32M |
| 2 |
Renaissance Technologies
New York
|
+$207K |
| 3 |
VF
Virtu Financial
New York
|
+$94.1K |
| 4 |
SC
Scotia Capital
Toronto,
Ontario, Canada
|
+$65K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
+$56.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$4.45M |
| 2 |
Westfield Capital Management
Boston,
Massachusetts
|
-$1.46M |
| 3 |
TA
Tamarack Advisers
Carlsbad,
California
|
-$170K |
| 4 |
AIS
AlphaOne Investment Services
West Chester,
Pennsylvania
|
-$109K |
| 5 |
CG
Cutler Group
San Francisco,
California
|
-$55K |
CORV Hedge Fund Activity: Q3 2017 in Review
31 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) for Q3 2017, worth a combined $38.7M — down 54% from $84.2M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new CORV positions and 3 closed out — a net gain of 4 holders — while 7 added to existing stakes and 12 trimmed.
The largest buyer was Stonepine Capital Management, adding an estimated $4.32M. The largest seller was Putnam Investments, cutting an estimated $4.45M.
- 31 institutional investors held Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) as of Q3 2017, up from 27 in Q2 2017.
- Funds reported $38.7M of Correvio Pharma Corp. Ordinary Shares (Canada) stock for Q3 2017, down 54% quarter-over-quarter.
- 7 funds opened new Correvio Pharma Corp. Ordinary Shares (Canada) positions in Q3 2017 and 3 closed out, a net change of +4 holders.
- The largest Correvio Pharma Corp. Ordinary Shares (Canada) buyer in Q3 2017 was Stonepine Capital Management, an estimated $4.32M added.
- The largest Correvio Pharma Corp. Ordinary Shares (Canada) seller in Q3 2017 was Putnam Investments, an estimated $4.45M sold.
Based on aggregated 13F filings for Q3 2017.